Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.Cancer Immunology Research|September 4, 2016
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T CellsBlanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, et al.Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistanceYapeng Su, Wei Wei, Lidia Robert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group studyJorge Aparicio, Pablo Maroto, Xavier García del Muro, et al.Nature Communications|December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJudith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.Nature Communications|May 13, 2020
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell lineYapeng Su, Melissa E Ko, Hanjun Cheng, et al.Pageof 3